INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 17, 2008 |
SVP, Clinical Development
Trans History: 208
|
SVP, Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
| Dec 17, 2008 |
VP, Regul Devel & Med Safety
Trans History: 288
|
VP, Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,952 | -- | 5,952 |
| Dec 17, 2008 |
VP, Regul Devel & Med Safety
Trans History: 288
|
VP, Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 24,048 | -- | 24,048 |
| Dec 17, 2008 |
Director, President & CEO
Trans History: 427
|
Director, President & CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 187,500 | -- | 312,500 |
| Dec 17, 2008 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 427
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 125,000 | -- | 125,000 |
| Dec 17, 2008 |
SVP, Research & Devel Sciences
Trans History: 660
|
SVP, Research & Devel Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,952 | -- | 5,952 |
| Dec 17, 2008 |
SVP, Research & Devel Sciences
Trans History: 660
|
SVP, Research & Devel Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,048 | -- | 44,048 |
| Dec 17, 2008 |
SVP, Commercial
Trans History: 172
|
SVP, Commercial | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,952 | -- | 5,952 |
| Dec 17, 2008 |
SVP, Commercial
Trans History: 172
|
SVP, Commercial | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 26,548 | -- | 26,548 |
| Dec 17, 2008 |
Director
Trans History: 742
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,952 | -- | 5,952 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.